AIMCA
MIRM icon

Alberta Investment Management Corp (AIMCo)’s Mirum Pharmaceuticals MIRM Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,310
Closed -$267K – 1128
2023
Q2 		$267K Hold
10,310
– – ﹤0.01% 1075
2023
Q1 		$248K Buy
+10,310
New +$235K ﹤0.01% 1131

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s MIRM Position: Q3 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of Mirum Pharmaceuticals (MIRM) in Q3 2023, closing a stake of 10,310 shares — an estimated $267K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in MIRM in Q1 2023 and held it in 2 quarters. The position peaked at $267K in Q2 2023. 159 funds tracked by Wall St. Rank hold MIRM as of Q3 2023.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Mirum Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 10,310 Mirum Pharmaceuticals shares in Q3 2023, an estimated $267K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Mirum Pharmaceuticals in Q1 2023 and held it in 2 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Mirum Pharmaceuticals position peaked at $267K in Q2 2023.
  • 159 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2023, filed 14 Nov 2023.